Skip to main content

Table 4 Distribution of evaluated patients for every measure and improvement proportion related to the AASTRE (IPR-AASTRE)

From: Impact of random safety analyses on structure, process and outcome indicators: multicentre study

  Evaluated patients (IPR-AASTRE, %)
Total
Evaluated patients (IPR-AASTRE, %)
Quarter 1
Evaluated patients (IPR-AASTRE, %)
Quarter 2
Evaluated patients (IPR-AASTRE, %)
Quarter 3
p
Block 1. Mechanical ventilation
 1. Alveolar pressure limit 124 (26.6) 71 (26.8) 20 (45.0) 33 (15.2) 0.12
 2. Mechanical ventilation alarms 398 (31.2) 155 (34.2) 119 (33.6) 124 (25.0) 0.001
 3. Tolerance to spontaneous ventilation 175 (1.1) 59 (1.7) 56 (0.0) 60 (1.7) 0.62
 4. Suitable current volume 336 (1.5) 17 (2.6) 107 (0.9) 112 (0.9) 0.47
Block 2. Haemodynamics
 5. Monitor alarms 557 (21.5) 223 (23.3) 142 (23.9) 192 (17.7) <0.0001
 6. Water balance and fluid adjustment 557 (1.1) 223 (0.5) 142 (0.7) 192 (2.8) 0.36
 7. Adequate haemodynamic monitoring 556 (0.4) 223 (0.0) 141 (0.7) 192 (0.5) 0.49
 8. Fluid therapy and amines adjustment according to monitoring 93 (1.1) 40 (0.0) 19 (0.0) 34 (2.9) 0.41
Block 3. Renal function and CRRT
 9. Acute renal failure assessment 654 (11.8) 280 (14.6) 160 (10.6) 214 (8.9) 0.03
 10. CRRT treatment prescription 27 (3.7) 13 (0.0) 6 (0.0) 8 (12.5) 0.29
 11. CRRT monitoring 28 (0.0) 14 (0.0) 6 (0.0) 8 (0.0) Not calculable
Block 4. Sedation/analgesia
 12. Evaluation of sedation level and pain of sedated patient 199 (11.6) 86 (15.1) 61 (9.8) 52 (7.7) 0.30
 13. Pain assessment in non-sedated patient 396 (8.6) 137 (13.1) 110 (5.5) 149 (6.7) 0.19
 14. Oversedation prevention 132 (9.8) 65 (10.8) 42 (2.4) 25 (20.0) 0.16
Block 5. Treatment (1)
 15. Check drug allergies and intolerances in patient’s medical history 623 (4.8) 268 (4.1) 161 (6.8) 194 (1.6) 0.10
 16. Correct prescription of daily treatment orders 623 (4.8) 268 (5.6) 161 (4.9) 194 (3.6) 0.66
 17. Adequate indication and dosage of the prescribed medication 622 (3.9) 268 (4.9) 160 (3.8) 194 (2.6) 0.37
 18. Prescribed treatment administered correctly. Verbal orders 623 (1.9) 268 (3.4) 161 (0.0) 194 (1.6) <0.0001
Block 6. Treatment (2)
 19. Prevention of thromboembolic disease 549 (4.9) 249 (7.2) 146 (3.4) 154 (2.6) 0.04
 20. Prophylaxis of gastrointestinal haemorrhage 587 (0.3) 266 (0.4) 159 (0.0) 162 (0.6) 0.63
 21. Control of hyperglycaemia 588 (1.4) 264 (1.5) 160 (1.3) 164 (1.2) 0.85
 22. Assessment of the antibiotic treatment 436 (2.3) 195 (3.1) 119 (0.8) 122 (2.5) 0.43
 23. Appropriate transfusion 554 (0.2) 233 (0.0) 157 (0.6) 164 (0.0) 0.49
Block 7. Techniques and tests
 24. Checking of X-ray slides 539 (1.5) 186 (1.6) 165 (2.4) 188 (0.5) 0.34
 25. Daily assessment of the need for catheters 624 (16.8) 225 (16.0) 183 (19.7) 216 (15.3) 0.46
Block 8. Nutrition
 26. Monitoring of enteral nutrition 487 (24.6) 241 (27.0) 117 (27.4) 129 (17.8) 0.11
 27. Daily assessment by parenteral nutrition team 78 (23.1) 24 (4.2) 25 (24.0) 29 (37.9) 0.04
Block 9. Nursing care
 28. Verification of endotracheal tube cuff pressure 436 (0.5) 195 (0.0) 127 (0.8) 114 (0.9) 0.58
 29. Oral hygiene with chlorhexidine (0.12–0.2%) 476 (0.4) 217 ((0.5) 138 (0.7) 121 (0.0) 0.52
 30. Daily assessment of the risk of developing pressure ulcers 563 (12.3) 282 (18.1) 151 (6.6) 130 (6.2) <0.0001
 31. Daily assessment of the protective measures for the safe handling of the patient 557 (1.1) 281 (1.1) 148 (1.4) 128 (0.8) 0.47
 32. Semi-recumbent position 433 (21.7) 196 (20.9) 123 (24.4) 114 (20.2) 0.48
Block 10. Structure
 33. Unequivocal patient identification 594 (12.5) 243 (14.4) 190 (12.1) 161 (9.9) 0.42
 34. Patient clinical information properly structured in the medical history 592 (24.8) 243 (26.3) 189 (29.1) 160 (17.5) 0.06
 35. Life-sustaining treatment limit sheet updated 82 (9.8) 30 (10.0) 22 (4.5) 30 (13.3) 0.44
 36. Correct position of bed rails 584 (0.3) 240 (0.8) 185 (0.0) 159 (0.0) 0.24
 37. Information to family members 592 (0.2) 242 (0.4) 189 (0.0) 161 (0.0) 0.46
  1. CRRT continuous renal replacement techniques